Where to Buy Retatrutide in Dubai and the UAE (2026)

UAE retatrutide availability snapshot — May 2026

Retatrutide (Eli Lilly's investigational triple agonist LY-3437943, GLP-1 + GIP + glucagon) is currently in Phase 3 development. As of May 2026 it has no MoHAP marketing authorisation, no UAE FDA registration, and is not stocked at retail pharmacies in any emirate. It is not a substance UAE clinicians can prescribe under standard medical practice.

What does exist in the UAE is research-use availability: synthetic retatrutide supplied for in-vitro laboratory work under UAE MoHAP Circular 17/2022 (the research-use compliance framework). This is a different supply category from pharmacy-dispensed prescription medicines such as Mounjaro (tirzepatide) or Ozempic (semaglutide), which require a UAE-licensed prescriber and a retail pharmacy.

Who supplies retatrutide in the UAE

Verified UAE research-use suppliers carry the following features: a traceable UAE address, batch-specific HPLC purity COA from a recognised independent lab, published batch numbers, a verified WhatsApp contact channel, and explicit research-use-only labelling consistent with MoHAP Circular 17/2022.

Remy Peptides is the publisher of this page and operates from Al Barsha 1, Dubai. The published Retatrutide range includes:

• Retatrutide 30mg pen — Janoshik batch RETP002, 99.262% HPLC, flagship format
• Retatrutide 20mg pen — Janoshik batch RET-20-C-2604-001, 99.841% HPLC (highest published purity in the Remy range)
• Retatrutide 10mg pen — entry-tier pen format
• Retatrutide 10mg vial — Janoshik batch RET-20-V-2604-001, 99.741% HPLC, lyophilized
• Retatrutide 40mg vial — large-format lyophilized vial

Each batch identifier above is verifiable in the public Remy Peptides COA library. The verification key for the 20mg pen Janoshik task is published on the COA page.

AED pricing across pen and vial formats

Current research-use pricing (May 2026, AED, valid through 2026-12-31):

The AED-per-milligram column is the apples-to-apples figure when comparing formats for a research protocol. Vials carry the lowest unit cost; pens carry a usability premium (no reconstitution, click-metered dispensing). The published price list applies only to verified research-use units and is not equivalent to clinical-prescription pricing for approved GLP-1 medicines.

Delivery zones across the UAE and GCC

Cold-chain logistics from the Al Barsha 1 dispatch point cover:

• Dubai: same-day delivery when an order is confirmed before 4 PM. Insulated, temperature-monitored packaging.
• Abu Dhabi, Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah, Fujairah: next-day cold-chain delivery when ordered before 12 PM.
• GCC export (Saudi Arabia, Qatar, Kuwait, Bahrain, Oman): handled case-by-case with destination-country compliance review before dispatch. Buyer is responsible for local import permissions where required.

Dubai summer ambient temperatures regularly exceed 45°C. The cold-chain requirement is non-negotiable for pen and vial integrity — ambient-shipped retatrutide is a quality red flag.

COA and batch verification before purchase

The single most important verification check is reading a batch-specific COA before agreeing to a price. The questions a research buyer should be able to answer from the supplier's COA:

• Which third-party lab performed the analysis (Janoshik Analytical is the published standard in the Remy range)
• Specific batch number and the date the analysis was performed
• HPLC purity result (Remy published Retatrutide batches range 99.262% to 99.841%)
• Assay result confirming retatrutide identity
• Endotoxin, residual TFA, and heavy-metals panel where applicable
• Verification key or task ID for independent confirmation

The how to verify a Janoshik COA guide walks through the lookup process. Suppliers who cannot produce a batch-specific COA, or who present generic certificates not linked to the dispatched batch, should be treated as unverified.

Red flags in unverified UAE retatrutide listings

Common indicators of compromised supply in the UAE grey market:

• Pricing significantly below AED 1,400 per 30mg pen (the AED 1,500 5+ tier is the floor of verified-purity supply)
• No batch-specific COA, or COAs from labs that do not allow public verification
• Ambient or unrefrigerated shipping (cold-chain is mandatory)
• No verified physical UAE address or only WhatsApp contact with no broader contact verification path
• Marketing copy that includes human-dosing instructions, treatment claims, or therapeutic positioning (this is the FDA-flagged "research use only" workaround pattern; UAE MoHAP applies similar scrutiny)
• Substitution: marketing tirzepatide or semaglutide alongside "retatrutide" without distinct batch documentation

Pen vs vial — which research format fits which workflow

Pens are pre-reconstituted, calibrated dose-delivery devices: 0.1mg per click on the 30mg pen, no reconstitution required. Vials are lyophilized powder for research workflows that need flexibility on concentration or that prefer reconstituted-on-demand stock. Pens carry a usability premium; vials carry the lowest AED-per-mg cost.

For research-context selection, see retatrutide dosage comparison and the retatrutide pen guide. For mg-to-click lookup specific to the 30mg pen, the retatrutide pen clicks guide covers the click math; the retatrutide dosage calculator handles protocol-length estimation.

How to order from Remy Peptides

Order placement: select a format from the product pages linked above, choose a tier (single, 3-pack, 5+ pack), and submit. Each order is confirmed via WhatsApp before dispatch — this is where destination, qualification, and intended-use are reviewed. Dubai orders confirmed before 4 PM ship same day. For contact verification, the contact verification page documents the official channels.

Why retatrutide differs from Mounjaro and Ozempic in the UAE

Mounjaro (tirzepatide) and Ozempic / Wegovy (semaglutide 1mg / 2.4mg) are both MoHAP-approved in the UAE and are dispensed by retail pharmacies under prescription from a UAE-licensed physician. Mounjaro UAE pricing in 2026 sits at approximately AED 1,734 per KwikPen at major pharmacies. Wegovy is similarly available under prescription. Ozempic in Dubai ranges roughly AED 744–1,800 per month depending on dose.

Retatrutide occupies a different category entirely: investigational, no MoHAP authorisation, no pharmacy stock, and supplied only as a research-use compound. The 28.7% mean weight-loss readout from TRIUMPH-4 (Eli Lilly, December 2025) makes retatrutide the strongest published efficacy compound in the GLP-1 class — but UAE access remains research-only until an NDA is filed and approved. See the TRIUMPH trial tracker for current Phase 3 readouts.

Research-use notes

Remy Peptides supplies retatrutide for in-vitro laboratory research only under UAE MoHAP Circular 17/2022. Nothing on this page is medical advice, prescribing guidance, or a treatment recommendation. Buyers are responsible for verifying their own institutional research-use authorisation and any local import permissions where applicable. Suppliers who pair research-use labelling with human-dosing instructions are operating outside the framework MoHAP and the FDA both apply.